Skip to main content
Top
Published in: Inflammation 3/2010

01-06-2010

Cellular and Molecular Characterization of Ozone-Induced Pulmonary Inflammation in the Cynomolgus Monkey

Authors: Alexandra Hicks, Galina Kourteva, Holly Hilton, Hongli Li, Tai-An Lin, Will Liao, Ying Li, Xin Wei, Thomas March, Janet Benson, Louis M. Renzetti

Published in: Inflammation | Issue 3/2010

Login to get access

Abstract

We investigated the cellular and molecular effects of ozone exposure in Cynomolgus monkeys. Thirty-six Cynomolgus monkeys were exposed to single or repeat ozone challenge. Pulmonary inflammation was assessed using bronchoalveolar lavage fluid (BAL) and histology. Gene expression profiling in lung and blood was performed. Ozone challenge evoked BAL cellular inflammation and increases in total protein, alkaline phosphatase and cytokines. Lung histology revealed cellular inflammation and epithelial necrosis. Gene expression profiling identified oxidative phosphorylation, immune response and cell adhesion pathways altered in response to ozone, with common and unique profiles in lung and blood. Lipocalin 2, CD177, the FK-506 and S100A8 binding proteins and ST-2 represent novel peripheral biomarkers of ozone toxicity. Repeat ozone challenge evoked reproducible inflammation but attenuated cell damage. These studies provide data on the molecular mechanisms and biomarker identification of ozone-evoked toxicity, and support the use of the Cynomolgus monkey as a model of human ozone challenge.
Literature
1.
go back to reference MacNee, W., and K. Donaldson. 2000. Exacerbations of COPD: Environmental mechanisms. Chest 117: 390S–379S.CrossRefPubMed MacNee, W., and K. Donaldson. 2000. Exacerbations of COPD: Environmental mechanisms. Chest 117: 390S–379S.CrossRefPubMed
2.
go back to reference Jorres, R.A., O. Holz, W. Zachgo, P. Timm, S. Koschyk, B. Muller, F. Grimminger, W. Seeger, F.J. Kelly, C. Dunster, T. Frischer, G. Lubec, M. Waschewski, A. Niendorf, and H. Magnussen. 2000. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. American Journal of Respiratory and Critical Care Medicine 161: 1855–1861.PubMed Jorres, R.A., O. Holz, W. Zachgo, P. Timm, S. Koschyk, B. Muller, F. Grimminger, W. Seeger, F.J. Kelly, C. Dunster, T. Frischer, G. Lubec, M. Waschewski, A. Niendorf, and H. Magnussen. 2000. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. American Journal of Respiratory and Critical Care Medicine 161: 1855–1861.PubMed
3.
go back to reference Sterner-Kock, A., M. Kock, R. Braun, and D.M. Hyde. 2000. Ozone-induced epithelial injury in the ferret is similar to nonhuman primates. American Journal of Respiratory and Critical Care Medicine 162: 1152–1156.PubMed Sterner-Kock, A., M. Kock, R. Braun, and D.M. Hyde. 2000. Ozone-induced epithelial injury in the ferret is similar to nonhuman primates. American Journal of Respiratory and Critical Care Medicine 162: 1152–1156.PubMed
4.
go back to reference Holz, O., R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, R.S.J. Vessey, S. Janicki, H. Magnussen, R.A. Jorres, K. Richter, O. Holz, R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, and R.S.J. Vessey. 2005. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. Journal of Clinical Pharmacology 45: 498–503.CrossRefPubMed Holz, O., R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, R.S.J. Vessey, S. Janicki, H. Magnussen, R.A. Jorres, K. Richter, O. Holz, R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, and R.S.J. Vessey. 2005. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. Journal of Clinical Pharmacology 45: 498–503.CrossRefPubMed
5.
go back to reference Seltzer, J., B.G. Bigby, M. Stulbarg, M.J. Holtzman, J.A. Nadel, I.F. Ueki, G.D. Leikauf, E.J. Goetz, and H.A. Boushey. 1986. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. Journal of Applied Physiology 60: 1321–1326.PubMed Seltzer, J., B.G. Bigby, M. Stulbarg, M.J. Holtzman, J.A. Nadel, I.F. Ueki, G.D. Leikauf, E.J. Goetz, and H.A. Boushey. 1986. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. Journal of Applied Physiology 60: 1321–1326.PubMed
6.
go back to reference Schelegle, E.S., W.F. Walby, M.F. Alfaro, V.J. Wong, L. Putney, M.Y. Stovall, A. Sterner-Kock, D.M. Hyde, and C.G. Plopper. 2003. Repeated episodes of ozone inhalation attenuates airway injury/repair and release of substance P, but not adaptation. Toxicology and Applied Pharmacology 186: 127–142.CrossRefPubMed Schelegle, E.S., W.F. Walby, M.F. Alfaro, V.J. Wong, L. Putney, M.Y. Stovall, A. Sterner-Kock, D.M. Hyde, and C.G. Plopper. 2003. Repeated episodes of ozone inhalation attenuates airway injury/repair and release of substance P, but not adaptation. Toxicology and Applied Pharmacology 186: 127–142.CrossRefPubMed
7.
go back to reference Kanniess, F., S. Khalilieh, A. Ludwig-Sengpiel, P. Stryszak, P. Soni, O. Holz, and H. Magnussen. 2007. SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects. European Respiratory Journal 51: 209S. Kanniess, F., S. Khalilieh, A. Ludwig-Sengpiel, P. Stryszak, P. Soni, O. Holz, and H. Magnussen. 2007. SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects. European Respiratory Journal 51: 209S.
8.
go back to reference Plopper, C.G., and D.M. Hyde. 2008. The non-human primate as a model for studying COPD and asthma. Pulmonary Pharmacology & Therapeutics 21: 755–766.CrossRef Plopper, C.G., and D.M. Hyde. 2008. The non-human primate as a model for studying COPD and asthma. Pulmonary Pharmacology & Therapeutics 21: 755–766.CrossRef
9.
go back to reference Hicks, A., J. Benson, T. March, and L. Renzetti. 2007. Ozone inhalation produces reproducible lung inflammation in the Cynomolgus monkey. European Respiratory Journal 51: 134S. Hicks, A., J. Benson, T. March, and L. Renzetti. 2007. Ozone inhalation produces reproducible lung inflammation in the Cynomolgus monkey. European Respiratory Journal 51: 134S.
10.
go back to reference Kourteva, G., H. Hilton, X. Wei, Y.L. Li, T. March, J. Benson, J.A. Rosinski, and A. Hicks. 2008. Lung and blood gene expression profiles from Cynomolgus monkeys exposed to ozone. FASEB Journal 22: lb212. Kourteva, G., H. Hilton, X. Wei, Y.L. Li, T. March, J. Benson, J.A. Rosinski, and A. Hicks. 2008. Lung and blood gene expression profiles from Cynomolgus monkeys exposed to ozone. FASEB Journal 22: lb212.
11.
go back to reference Gentleman, R., V.J. Carey, and W. Huber. 2005. Bioinformatics and computational biology solutions using R and bioconductor. (Statistics for Biology and Health). Springer. Gentleman, R., V.J. Carey, and W. Huber. 2005. Bioinformatics and computational biology solutions using R and bioconductor. (Statistics for Biology and Health). Springer.
12.
go back to reference Krishna, M.T., J. Madden, L.M. Teran, G.L. Biscione, L.C.K. Lau, N.J. Withers, T. Sandstrom, I. Mudway, F.J. Kelly, A. Walls, A.J. Frew, and S.T. Holgate. 1998. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. European Respiratory Journal 11: 1294–1300.CrossRefPubMed Krishna, M.T., J. Madden, L.M. Teran, G.L. Biscione, L.C.K. Lau, N.J. Withers, T. Sandstrom, I. Mudway, F.J. Kelly, A. Walls, A.J. Frew, and S.T. Holgate. 1998. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. European Respiratory Journal 11: 1294–1300.CrossRefPubMed
13.
go back to reference Kooter, I.M., J.L.A. Pennings, P.H.B. Fokkens, D.L.A.C. Leseman, A.J.F. Boere, M.E. Gerlofs-Nijland, F.R. Cassee, J.A.C. Schalk, T.J.H. Orzechowski, M.M. Schaap, T.M. Breit, J.A.M.A. Dormans, C.T.M. van Oostrom, A. de Vries, and H. van Steeg. 2007. Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status. Journal of Applied Physiology 102: 1185–1192.CrossRefPubMed Kooter, I.M., J.L.A. Pennings, P.H.B. Fokkens, D.L.A.C. Leseman, A.J.F. Boere, M.E. Gerlofs-Nijland, F.R. Cassee, J.A.C. Schalk, T.J.H. Orzechowski, M.M. Schaap, T.M. Breit, J.A.M.A. Dormans, C.T.M. van Oostrom, A. de Vries, and H. van Steeg. 2007. Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status. Journal of Applied Physiology 102: 1185–1192.CrossRefPubMed
14.
go back to reference Chang, M.M., R. Wu, C.G. Plopper, and D.M. Hyde. 1998. IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury. American Journal of Physiology 275: L524–L532.PubMed Chang, M.M., R. Wu, C.G. Plopper, and D.M. Hyde. 1998. IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury. American Journal of Physiology 275: L524–L532.PubMed
15.
go back to reference Johnston, R.A., J.P. Mizgerd, and S.A. Shore. 2005. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L61–L67.CrossRefPubMed Johnston, R.A., J.P. Mizgerd, and S.A. Shore. 2005. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L61–L67.CrossRefPubMed
16.
go back to reference Yu, M., X. Zheng, H. Witschi, and K.E. Pinkerton. 2002. The role of interleukin 6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Tox Sci 68: 488–497.CrossRef Yu, M., X. Zheng, H. Witschi, and K.E. Pinkerton. 2002. The role of interleukin 6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Tox Sci 68: 488–497.CrossRef
17.
go back to reference Kierstein, S., F.R. Poulain, Y. Cao, M. Grous, R. Mathias, G. Kierstein, M.F. Beers, M. Salmon, R.A. Panettieri Jr., and A. Haczku. 2006. Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respiratory Research 7: 85–94.CrossRefPubMed Kierstein, S., F.R. Poulain, Y. Cao, M. Grous, R. Mathias, G. Kierstein, M.F. Beers, M. Salmon, R.A. Panettieri Jr., and A. Haczku. 2006. Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respiratory Research 7: 85–94.CrossRefPubMed
18.
go back to reference Kierstein, S., K. Krytska, S. Sharma, Y. Amrani, M. Salmon, R.A. Panettieri Jr., J. Zangrilli, and A. Haczku. 2008. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 63: 438–446.CrossRefPubMed Kierstein, S., K. Krytska, S. Sharma, Y. Amrani, M. Salmon, R.A. Panettieri Jr., J. Zangrilli, and A. Haczku. 2008. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 63: 438–446.CrossRefPubMed
19.
go back to reference Potter-Perigo, S., E.D. Kaplan, D.L. Luchtel, C. Baker, L.C. Altman, and T.N. Wight. 1998. Ozone alters the expression of tenascin-C in cultured primate nasal epithelial cells. American Journal of Respiratory Cell and Molecular Biology 18: 471–478.PubMed Potter-Perigo, S., E.D. Kaplan, D.L. Luchtel, C. Baker, L.C. Altman, and T.N. Wight. 1998. Ozone alters the expression of tenascin-C in cultured primate nasal epithelial cells. American Journal of Respiratory Cell and Molecular Biology 18: 471–478.PubMed
20.
go back to reference Hoshino, M., S. Morita, H. Iwashita, Y. Sagiya, T. Nagi, A. Nakanishi, Y. Ashida, O. Nishimura, Y. Fujisawa, and M. Fujino. 2002. Increased expression of the human Ca2+-activates Cl− channel 1 (CaCC1) gene in the asthmatic airway. American Journal of Respiratory and Critical Care Medicine 165(8): 1132–1138.PubMed Hoshino, M., S. Morita, H. Iwashita, Y. Sagiya, T. Nagi, A. Nakanishi, Y. Ashida, O. Nishimura, Y. Fujisawa, and M. Fujino. 2002. Increased expression of the human Ca2+-activates Cl channel 1 (CaCC1) gene in the asthmatic airway. American Journal of Respiratory and Critical Care Medicine 165(8): 1132–1138.PubMed
21.
go back to reference Hauber, H.P., C. Bergeron, A. Tsicopoulos, B. Wallaert, R. Olivenstein, K.J. Holroyd, R.C. Levitt, and Q. Hamid. 2005. Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Canadian Respiratory Journal 12(3): 143–146.PubMed Hauber, H.P., C. Bergeron, A. Tsicopoulos, B. Wallaert, R. Olivenstein, K.J. Holroyd, R.C. Levitt, and Q. Hamid. 2005. Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Canadian Respiratory Journal 12(3): 143–146.PubMed
22.
go back to reference Williams, A.S., R. Issa, S.Y. Leung, P. Nath, G.D. Ferguson, B.L. Bennett, I.M. Adcock, and K.F. Chung. 2007. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-jun NH2 terminal kinase inhibitor SP600125. Journal of Pharmacology and Experimental Therapeutics 322: 351–359.CrossRefPubMed Williams, A.S., R. Issa, S.Y. Leung, P. Nath, G.D. Ferguson, B.L. Bennett, I.M. Adcock, and K.F. Chung. 2007. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-jun NH2 terminal kinase inhibitor SP600125. Journal of Pharmacology and Experimental Therapeutics 322: 351–359.CrossRefPubMed
23.
go back to reference Lim, S.Y., M. Raftery, H. Cai, K. Hsu, W.X. Yan, H.L. Hseih, R.N. Watts, D. Richardson, S. Thomas, M. Perry, and C.L. Geczy. 2008. S-Nitrosylated S100A8: Novel anti-inflammatory properties. Journal of Immunology 181: 5627–5636. Lim, S.Y., M. Raftery, H. Cai, K. Hsu, W.X. Yan, H.L. Hseih, R.N. Watts, D. Richardson, S. Thomas, M. Perry, and C.L. Geczy. 2008. S-Nitrosylated S100A8: Novel anti-inflammatory properties. Journal of Immunology 181: 5627–5636.
24.
go back to reference Arend, W.P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunological Reviews 223: 20–38.CrossRefPubMed Arend, W.P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunological Reviews 223: 20–38.CrossRefPubMed
25.
go back to reference Sunhil, V.R., K.J. Patel, M. Nilsen-Hamilton, D.E. Heck, J.D. Laskin, and D.L. Laskin. 2007. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 83: 177–187.CrossRef Sunhil, V.R., K.J. Patel, M. Nilsen-Hamilton, D.E. Heck, J.D. Laskin, and D.L. Laskin. 2007. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 83: 177–187.CrossRef
26.
go back to reference Andre, E., T. Stoeger, S. Takenaka, M. Bahnweg, B. Ritter, E. Karg, B. Lentner, C. Reinhard, H. Schulz, and M. Wjst. 2006. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. European Respiratory Journal 28: 275–285.CrossRefPubMed Andre, E., T. Stoeger, S. Takenaka, M. Bahnweg, B. Ritter, E. Karg, B. Lentner, C. Reinhard, H. Schulz, and M. Wjst. 2006. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. European Respiratory Journal 28: 275–285.CrossRefPubMed
27.
go back to reference Keatings, V.M., and P.J. Barnes. 1997. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. American Journal of Respiratory and Critical Care Medicine 155(2): 449–453.PubMed Keatings, V.M., and P.J. Barnes. 1997. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. American Journal of Respiratory and Critical Care Medicine 155(2): 449–453.PubMed
28.
go back to reference Sachs, U.J.H., C.L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V.V. Orlova, E.Y. Choi, P.J. Newman, K.T. Preissner, T. Chavakis, and S. Santoso. 2007. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). Journal of Biological Chemistry 282(32): 23603–23612.CrossRefPubMed Sachs, U.J.H., C.L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V.V. Orlova, E.Y. Choi, P.J. Newman, K.T. Preissner, T. Chavakis, and S. Santoso. 2007. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). Journal of Biological Chemistry 282(32): 23603–23612.CrossRefPubMed
29.
go back to reference Sun, J., and K.F. Chung. 1997. Airway inflammation despite loss of bronchial hyperresponsiveness after multiple ozone exposures. Respiratory Medicine 91: 47–55.CrossRefPubMed Sun, J., and K.F. Chung. 1997. Airway inflammation despite loss of bronchial hyperresponsiveness after multiple ozone exposures. Respiratory Medicine 91: 47–55.CrossRefPubMed
30.
go back to reference van Bree, L., J.A.M.A. Dormans, H.S. Koren, R.B. Devlin, and P.J.A. Rombout. 2002. Attenuation and recovery of pulmonary injury in rats following short-term, repeated daily exposure to ozone. Inhalation Toxicology 14: 883–900.CrossRefPubMed van Bree, L., J.A.M.A. Dormans, H.S. Koren, R.B. Devlin, and P.J.A. Rombout. 2002. Attenuation and recovery of pulmonary injury in rats following short-term, repeated daily exposure to ozone. Inhalation Toxicology 14: 883–900.CrossRefPubMed
31.
go back to reference Tepper, J.S., D.L. Costa, J.R. Lehmann, M.F. Weber, and G.E. Hatch. 1989. Unattenuated structural and biochemical alterations in the rat lung during functional adaptation to ozone. American Review of Respiratory Disease 140: 493–501.PubMed Tepper, J.S., D.L. Costa, J.R. Lehmann, M.F. Weber, and G.E. Hatch. 1989. Unattenuated structural and biochemical alterations in the rat lung during functional adaptation to ozone. American Review of Respiratory Disease 140: 493–501.PubMed
32.
go back to reference Devlin, R.B., L.J. Folinsbee, F. Biscardi, G. Hatch, S. Becker, M.C. Madden, M. Robbins, and S.H. Koren. 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhalation Toxicology 9: 211–235.CrossRef Devlin, R.B., L.J. Folinsbee, F. Biscardi, G. Hatch, S. Becker, M.C. Madden, M. Robbins, and S.H. Koren. 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhalation Toxicology 9: 211–235.CrossRef
33.
go back to reference Barnes, P.J., B. Chowdhury, S.A. Kharitonov, H. Magnussen, C.P. Page, D. Postma, and M. Saetta. 2006. Pulmonary biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 174: 6–14.CrossRefPubMed Barnes, P.J., B. Chowdhury, S.A. Kharitonov, H. Magnussen, C.P. Page, D. Postma, and M. Saetta. 2006. Pulmonary biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 174: 6–14.CrossRefPubMed
34.
go back to reference Wang, I.M., S. Stepaniants, Y. Boie, J.R. Mortimer, B. Kennedy, M. Elliott, S. Hayashi, L. Loy, S. Coulter, S. Cervino, J. Harris, M. Thornton, R. Raubertas, C. Roberts, J.C. Hogg, M. Crackower, G. O’Neill, and P.D. Paré. 2008. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. American Journal of Respiratory and Critical Care Medicine 177: 402–411.CrossRefPubMed Wang, I.M., S. Stepaniants, Y. Boie, J.R. Mortimer, B. Kennedy, M. Elliott, S. Hayashi, L. Loy, S. Coulter, S. Cervino, J. Harris, M. Thornton, R. Raubertas, C. Roberts, J.C. Hogg, M. Crackower, G. O’Neill, and P.D. Paré. 2008. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. American Journal of Respiratory and Critical Care Medicine 177: 402–411.CrossRefPubMed
35.
go back to reference Di Stefano, A., G. Caramori, F.L. Ricciardolo, A. Capelli, I.M. Adcock, and C.F. Donner. 2004. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview. Clinical and Experimental Allergy 34: 1156–1167.CrossRefPubMed Di Stefano, A., G. Caramori, F.L. Ricciardolo, A. Capelli, I.M. Adcock, and C.F. Donner. 2004. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview. Clinical and Experimental Allergy 34: 1156–1167.CrossRefPubMed
Metadata
Title
Cellular and Molecular Characterization of Ozone-Induced Pulmonary Inflammation in the Cynomolgus Monkey
Authors
Alexandra Hicks
Galina Kourteva
Holly Hilton
Hongli Li
Tai-An Lin
Will Liao
Ying Li
Xin Wei
Thomas March
Janet Benson
Louis M. Renzetti
Publication date
01-06-2010
Publisher
Springer US
Published in
Inflammation / Issue 3/2010
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-009-9168-5

Other articles of this Issue 3/2010

Inflammation 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.